PBT fell 78.0% as HY22's one-off land sale windfall failed to repeat

The prior comparable half (HY22) was inflated by one-off high-value land sales and a land acquisition, a non-comparable base that management itself flags in commentary. This matters because the headline percentage declines overstate the deterioration in the underlying land-development business.

Beneath the revenue collapse, profitability per dollar of sale actually held up: PBT margin was 59.1%, within CDI's normal range, and NPAT margin was 42.2%, at the upper edge of the historical range. The effective tax rate was unchanged at 28.0% in both periods, so the PBT and NPAT declines move almost in lockstep (a 0.2 percentage-point gap) — tax is not distorting the read here.

Cash and equivalents rose 198.6% to NZ$45.0m from NZ$15.1m, while total liabilities fell 79.5%, pointing to a materially stronger balance sheet even as operating cash generation shrank.

The size of the profit decline is a function of sales timing, not eroding unit economics — margins remain within or above CDI's normal range. For an investor, this means the business model itself has not weakened; the pipeline of land sales has simply slowed relative to an unusually strong prior half.

Working-capital absorption is building. Operating working-capital movement was NZ$2.1m, at the upper edge of CDI's historical range against a mean of roughly NZ$-0.6m, driven partly by trade debtors rising 145.3% to NZ$3.6m. Debtor days rose to 55.9 from 5.7 in the prior half, though 55.9 days still sits within the company's normal historical range, so the jump reflects a low comparator rather than a new collection problem, but it is worth monitoring given the residential-development sales cycle.

Cash generation fell faster than the balance sheet suggests. Operating cash inflow dropped 76.9% to NZ$2.5m from NZ$10.8m, and free cash flow to NPAT conversion was 43.9%, a level with no prior-period comparator disclosed. The strong cash balance is therefore a legacy of prior-period land sale proceeds and debt paydown rather than evidence that current-period cash generation is healthy.

Management's own commentary points to softer market and consumer sentiment continuing through 2023, with an expectation of gradual improvement into 2024, but no measurable target accompanies that language. This leaves investors without a benchmark to judge whether the current run rate represents a trough or a new normal for land sale volumes.

Margins held within CDI's normal historical range, which suggests the underlying land-development and investment-property segments remain structurally profitable; residential land development contributed NZ$4.5m of segment result on NZ$10.7m of revenue, with investment property contributing a smaller but stable NZ$0.5m. However, the cash and working-capital picture is weaker: operating cash inflow fell faster than NPAT, working-capital absorption sits at the upper edge of historical range, and no capex or full free-cash-flow bridge was disclosed to confirm capital efficiency. ROE fell to 1.6% from 7.6%, still within CDI's normal range but weakening, which is consistent with a smaller profit base sitting on a stable, larger equity balance of NZ$305.3m.

This briefing cannot assess forward sales pipeline volumes, capex plans, or full-year dividend policy, none of which were disclosed with sufficient detail in this release.